Univ. Prof. Dr. Andreas Zirlik
Univ. Prof. Dr. Andreas Zirlik
Head of Dept. of Cardiology, LKH-University Hospital of the Medical University Graz, Austria
Verified email at medunigraz.at
TitleCited byYear
Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells
K Isoda, JL Young, A Zirlik, LA MacFarlane, N Tsuboi, N Gerdes, ...
Arteriosclerosis, thrombosis, and vascular biology 26 (3), 611-617, 2006
4252006
Ly-6Chigh Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium
I Hilgendorf, LMS Gerhardt, TC Tan, C Winter, TAW Holderried, ...
Circulation research 114 (10), 1611-1622, 2014
2732014
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1
A Zirlik, C Maier, N Gerdes, L MacFarlane, J Soosairajah, U Bavendiek, ...
Circulation 115 (12), 1571, 2007
1952007
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension
M Böhm, F Mahfoud, C Ukena, UC Hoppe, K Narkiewicz, M Negoita, ...
Hypertension 65 (4), 766-774, 2015
1562015
Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study
A Zirlik, SM Abdullah, N Gerdes, L MacFarlane, U Schönbeck, A Khera, ...
Arteriosclerosis, thrombosis, and vascular biology 27 (9), 2043-2049, 2007
1302007
Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study
JA De Lemos, A Zirlik, U Schönbeck, N Varo, SA Murphy, A Khera, ...
Arteriosclerosis, thrombosis, and vascular biology 25 (10), 2192-2196, 2005
1142005
TRAF-1,-2,-3,-5, and-6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells
A Zirlik, U Bavendiek, P Libby, L MacFarlane, N Gerdes, J Jagielska, ...
Arteriosclerosis, thrombosis, and vascular biology 27 (5), 1101-1107, 2007
972007
Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity
I Hilgendorf, I Theurl, LMS Gerhardt, CS Robbins, GF Weber, A Gonen, ...
Circulation 129 (16), 1677-1687, 2014
772014
CD40L induces inflammation and adipogenesis in adipose cells–a potential link between metabolic and cardiovascular disease
A Missiou, D Wolf, I Platzer, S Ernst, C Walter, P Rudolf, K Zirlik, N Köstlin, ...
Thrombosis and haemostasis 103 (04), 788-796, 2010
732010
Atherogenesis in Mice Does Not Require CD40 Ligand From Bone Marrow–Derived Cells
U Bavendiek, A Zirlik, S LaClair, L MacFarlane, P Libby, U Schönbeck
Arteriosclerosis, thrombosis, and vascular biology 25 (6), 1244-1249, 2005
722005
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis—but does not affect immunity and thrombosis in mice
D Wolf, JD Hohmann, A Wiedemann, K Bledzka, H Blankenbach, ...
Circulation research 109 (11), 1269-1279, 2011
692011
Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones
A Zirlik, A Leugers, J Lohrmann, S Ernst, BE Sobel, C Bode, TK Nordt
Thrombosis and haemostasis 91 (04), 674-682, 2004
662004
Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry
H Winkels, E Ehinger, M Vassallo, K Buscher, HQ Dinh, K Kobiyama, ...
Circulation research 122 (12), 1675-1688, 2018
632018
CLINICAL PERSPECTIVE
A Missiou, N Köstlin, N Varo, P Rudolf, P Aichele, S Ernst, C Münkel, ...
Circulation 121 (18), 2033-2044, 2010
562010
Co-stimulatory molecules in and beyond co-stimulation–tipping the balance in atherosclerosis?
N Gerdes, A Zirlik
Thrombosis and haemostasis 106 (11), 804-813, 2011
522011
The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice
I Hilgendorf, S Eisele, I Remer, J Schmitz, K Zeschky, C Colberg, ...
Arteriosclerosis, thrombosis, and vascular biology 31 (9), 1991-1999, 2011
512011
The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice
I Hilgendorf, S Eisele, I Remer, J Schmitz, K Zeschky, C Colberg, ...
Arteriosclerosis, thrombosis, and vascular biology 31 (9), 1991-1999, 2011
512011
Urine proteome analysis reflects atherosclerotic disease in an ApoE−/− mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis
C von zur Muhlen, E Schiffer, C Sackmann, P Zürbig, I Neudorfer, A Zirlik, ...
Molecular & Cellular Proteomics 11 (7), M111. 013847, 2012
452012
Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice
D Wolf, F Jehle, NA Michel, EN Bukosza, J Rivera, YC Chen, N Hoppe, ...
Circulation 129 (23), 2414-2425, 2014
442014
TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation
A Missiou, P Rudolf, P Stachon, D Wolf, N Varo, P Aichele, C Colberg, ...
Circulation research 107 (6), 757-766, 2010
422010
The system can't perform the operation now. Try again later.
Articles 1–20